A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection
Craig Fenwick, View ORCID ProfilePriscilla Turelli, Céline Pellaton, Alex Farina, Jérémy Campos, Charlène Raclot, Florence Pojer, Valeria Cagno, Giuseppe Pantaleo, Didier Trono
doi: https://doi.org/10.1101/2021.04.08.21255150
Craig Fenwick
1Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Priscilla Turelli
2School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Céline Pellaton
1Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Alex Farina
1Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Jérémy Campos
1Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Charlène Raclot
2School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Florence Pojer
2School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Valeria Cagno
3Department of Microbiology and Molecular Medicine, University of Geneva, Switzerland
4Institute of Microbiology, Lausanne University Hospital, University of Lausanne, Switzerland
Giuseppe Pantaleo
1Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
5Swiss Vaccine Research Institute, Lausanne University Hospital and University of Lausanne, Switzerland
Didier Trono
2School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Data Availability
The data that support the findings of this study are available from the corresponding authors
Posted April 13, 2021.
A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection
Craig Fenwick, Priscilla Turelli, Céline Pellaton, Alex Farina, Jérémy Campos, Charlène Raclot, Florence Pojer, Valeria Cagno, Giuseppe Pantaleo, Didier Trono
medRxiv 2021.04.08.21255150; doi: https://doi.org/10.1101/2021.04.08.21255150
A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection
Craig Fenwick, Priscilla Turelli, Céline Pellaton, Alex Farina, Jérémy Campos, Charlène Raclot, Florence Pojer, Valeria Cagno, Giuseppe Pantaleo, Didier Trono
medRxiv 2021.04.08.21255150; doi: https://doi.org/10.1101/2021.04.08.21255150
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12740)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4579)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4346)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)